| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3e9445e5e3626f36e932c6451a928250 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J21-003
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F7-2208
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F1-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F7-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J21-00 |
| filingDate |
1983-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9e83c7a27cdd44497c46ed1222af033 |
| publicationDate |
1984-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
DE-3344057-A1 |
| titleOfInvention |
A NEW LACTONE COMPOUND AND PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHOD FOR THE PRODUCTION THEREOF |
| abstract |
A lactone compound of the 20-spiroxane series of the formula <IMAGE> and the corresponding 17 beta -hydroxy-17 alpha -pregn-4-ene-21-carboxylic acid and its salts have a high aldosterone-antagonistic activity and can be used as potassium-sparing diuretics in the therapy of various types of hyperaldosteronism. The compounds can be obtained by conventional processes of steroid chemistry. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7417140-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7414127-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7411062-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7235655-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03082895-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03082895-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2005523306-A |
| priorityDate |
1982-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |